Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07054125 · ClinicalTrials.gov registry record

Continuous Glucose Monitoring, Diabetes Education, and Peer Support for Management of Uncontrolled Type 2 Diabetes

A clinical trial of Type 2 Diabetes Mellitus - Poor Control, sponsored by Whole Endo.

Recruiting
Registry status
100
Enrollment target
1
Study location

NCT07054125 is a study of Type 2 Diabetes Mellitus - Poor Control that is actively recruiting participants, run by Whole Endo. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07054125, a study of Type 2 Diabetes Mellitus - Poor Control, is actively recruiting participants, sponsored by Whole Endo.

RECRUITING
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

This research study is investigating whether a diabetes virtual group visit program using a continuous glucose monitor (CGM) can help improve glucose levels and quality of life in individuals with uncontrolled type 2 diabetes. People in the study will join group visits virtually to discuss using CGM, understanding CGM, and other information about ways to bring blood sugars to your goal (nutrition, movement, reducing stress, and techniques to start a new habit).

Interventions

  • BEHAVIORAL Education, lifestyle counseling, and peer support

Study Locations (1)

North Carolina

  • Whole Endo - Asheville

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-08-01
Est. Completion 2028-08

Sponsor

Whole Endo

1 total trials

What the Registry Record Tells You About NCT07054125

The ClinicalTrials.gov registry entry for NCT07054125 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Whole Endo, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 2 Diabetes Mellitus - Poor Control appearing as the primary indexed condition, and to 1 intervention - of which Education, lifestyle counseling, and peer support is the first listed.

NCT07054125 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT07054125 about?

NCT07054125 is a clinical study titled "Continuous Glucose Monitoring, Diabetes Education, and Peer Support for Management of Uncontrolled Type 2 Diabetes". This research study is investigating whether a diabetes virtual group visit program using a continuous glucose monitor (CGM) can help improve glucose levels and quality of life in individuals with uncontrolled type 2 diabetes. People in the study will join group visits virtually to discuss using CGM...

What is the current status of trial NCT07054125?

This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2025-08-01. Estimated completion is 2028-08.

What conditions does trial NCT07054125 study?

This clinical trial studies the following conditions: Type 2 Diabetes Mellitus - Poor Control.

What interventions are being tested in trial NCT07054125?

The interventions under investigation include: Education, lifestyle counseling, and peer support (BEHAVIORAL).

Who is sponsoring clinical trial NCT07054125?

This trial is sponsored by Whole Endo, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07054125 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes Mellitus - Poor Control

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.